Herbs (Global Traditional) · Ayurveda
Guggulu (Commiphora mukul) (Commiphora mukul)
Moderate Evidencebotanical
Hermetica Superfood Encyclopedia
Guggulu (Commiphora mukul) is an Ayurvedic resin containing guggulsterones, steroid compounds that may support cholesterol metabolism and inflammatory pathways. The primary bioactive compounds E- and Z-guggulsterones work through farnesoid X receptor modulation and sterol regulatory mechanisms.
Guggulu is a gum resin exudate obtained from the stem bark of the Commiphora mukul tree, native to arid regions of India and Pakistan. It is harvested through tapping, which involves making incisions or stripping the bark to allow the resin to ooze out and harden, yielding an oleo-gum resin comprising approximately 61% resin, 29.6% gum, 6.9% moisture, 0.6% volatile oil, and 3.2% insoluble substances.
The research dossier explicitly states that search results lack specific details on key human clinical trials, RCTs, or meta-analyses for guggulu, with no PMIDs or studies with sample sizes, designs, or outcomes described. While traditional use in Ayurveda spans over 3,000 years, modern clinical evidence is not provided in available sources.
No clinically studied dosage ranges for extracts, powder, or standardized forms are specified in the available research. Details on standardization (e.g., guggulsterone content) are not provided. Consult a healthcare provider before starting any new supplement.
Guggulu (Commiphora mukul) is not consumed as a food source and therefore lacks a conventional nutritional profile of macronutrients. It is valued entirely for its bioactive resinous compounds. **Key Bioactive Compounds:** • **Guggulsterones (E- and Z-isomers):** The primary pharmacologically active steroids, typically comprising ~1.0–5.0% of purified guggul resin (shuddha guggulu). Z-guggulsterone is generally considered the more bioactive isomer. These are C21 steroidal ketones derived from the pregnane skeleton. • **Guggulipid (standardized extract):** Commercially standardized to contain ~2.5–5% guggulsterones (combined E and Z forms). • **Myrrhanol A and Myrrhanone A:** Polypodane-type triterpenes found in smaller quantities. • **Mukulol (Z-guggulsterol):** A sterol present at ~0.2–0.5% of oleo-gum-resin. • **Guggulignan I and II:** Lignan compounds with reported antioxidant activity. • **Essential oils:** ~1.0–1.6% of crude oleo-gum-resin, containing eugenol, d-limonene, cineol, and sesquiterpenoids (including α-bisabolene and β-caryophyllene). • **Polysaccharides (gum fraction):** ~30–60% of crude resin; composed of arabinose, galactose, mannose, glucuronic acid, and 4-O-methylglucuronic acid residues; primarily structural/carrier, not directly bioactive. • **Phenolic acids:** Gallic acid (~0.05–0.2%), ellagic acid (trace to ~0.1%), and ferulic acid (trace amounts), contributing antioxidant properties. • **Diterpenoids:** Cembrene, cembrene A, and mukulol present in small fractions. • **Minerals (trace in crude resin):** Iron, manganese, zinc, and calcium in low, variable concentrations (not standardized). • **Resin fraction:** ~25–40% of crude material; contains steroidal and triterpenoid compounds. **Bioavailability Notes:** Guggulsterones have relatively low oral bioavailability due to poor aqueous solubility and significant first-pass hepatic metabolism. Studies in animal models suggest bioavailability of ~~30–40% for oral guggulsterone. Ayurvedic processing (shodhana, or purification with Triphala decoction, cow's milk, or cow's urine) is traditionally believed to enhance efficacy, and there is preliminary evidence that purification may alter the resin's chemical composition and reduce toxic diterpene content. Lipid-based formulations and nano-encapsulation have been explored to improve absorption. The gum fraction may modulate release kinetics. Co-administration with piperine (from black pepper, common in Ayurvedic polyherbal formulations) may enhance bioavailability by inhibiting glucuronidation.
Guggulsterones (E- and Z-forms) act as antagonists of the farnesoid X receptor (FXR), potentially influencing bile acid synthesis and cholesterol homeostasis. The compounds may also modulate inflammatory pathways through NF-κB inhibition and cytokine regulation. Antioxidant phenolic compounds like gallic acid and ellagic acid provide additional cellular protection mechanisms.
Clinical research on guggulu shows mixed results for cholesterol management, with some studies reporting 10-15% reductions in total cholesterol while others show no significant effects. Most human trials have been small-scale (30-100 participants) with varying standardization of extracts. Some studies suggest anti-inflammatory effects, but larger, well-controlled trials are needed to establish definitive therapeutic benefits. Traditional use evidence spans thousands of years but lacks modern scientific validation.
Common side effects include gastrointestinal upset, headache, and skin rash in sensitive individuals. Guggulu may interact with blood-thinning medications and thyroid hormones due to its influence on metabolic pathways. It should be avoided during pregnancy and breastfeeding due to insufficient safety data. People with liver disease should use caution as some cases of hepatotoxicity have been reported with concentrated extracts.
